CN106605904A - Chewable tablets containing acerola cherry powder and preparation method of chewable tablets - Google Patents
Chewable tablets containing acerola cherry powder and preparation method of chewable tablets Download PDFInfo
- Publication number
- CN106605904A CN106605904A CN201510684507.8A CN201510684507A CN106605904A CN 106605904 A CN106605904 A CN 106605904A CN 201510684507 A CN201510684507 A CN 201510684507A CN 106605904 A CN106605904 A CN 106605904A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- lubricant
- gained
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 82
- 239000007910 chewable tablet Substances 0.000 title claims abstract description 41
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 241000167854 Bourreria succulenta Species 0.000 title abstract description 9
- 235000019693 cherries Nutrition 0.000 title abstract description 9
- WVXRAFOPTSTNLL-NKWVEPMBSA-N 2',3'-dideoxyadenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1CC[C@@H](CO)O1 WVXRAFOPTSTNLL-NKWVEPMBSA-N 0.000 title abstract 3
- 235000014837 Malpighia glabra Nutrition 0.000 title abstract 3
- 241001640002 Malpighia emarginata Species 0.000 title 1
- 240000003394 Malpighia glabra Species 0.000 claims abstract description 38
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims abstract description 25
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims abstract description 24
- 239000002994 raw material Substances 0.000 claims abstract description 13
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 42
- 229940068682 chewable tablet Drugs 0.000 claims description 30
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims description 28
- 239000004386 Erythritol Substances 0.000 claims description 24
- 229940009714 erythritol Drugs 0.000 claims description 24
- 235000019414 erythritol Nutrition 0.000 claims description 24
- 239000011812 mixed powder Substances 0.000 claims description 24
- 239000000314 lubricant Substances 0.000 claims description 22
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 21
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 21
- 235000013399 edible fruits Nutrition 0.000 claims description 21
- 235000013325 dietary fiber Nutrition 0.000 claims description 20
- 229930182830 galactose Natural products 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 15
- 238000005469 granulation Methods 0.000 claims description 14
- 230000003179 granulation Effects 0.000 claims description 14
- 235000019359 magnesium stearate Nutrition 0.000 claims description 14
- 239000000463 material Substances 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 12
- 238000005303 weighing Methods 0.000 claims description 12
- 238000001035 drying Methods 0.000 claims description 10
- 239000002245 particle Substances 0.000 claims description 10
- 238000005550 wet granulation Methods 0.000 claims description 10
- 229920001353 Dextrin Polymers 0.000 claims description 9
- 239000004375 Dextrin Substances 0.000 claims description 9
- 235000019425 dextrin Nutrition 0.000 claims description 9
- 206010013786 Dry skin Diseases 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 2
- 230000006870 function Effects 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 244000298697 Actinidia deliciosa Species 0.000 abstract description 3
- 235000009436 Actinidia deliciosa Nutrition 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 230000032683 aging Effects 0.000 abstract description 2
- 235000009508 confectionery Nutrition 0.000 abstract description 2
- HEBKCHPVOIAQTA-NGQZWQHPSA-N d-xylitol Chemical compound OC[C@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-NGQZWQHPSA-N 0.000 abstract description 2
- UNXHWFMMPAWVPI-QWWZWVQMSA-N D-Threitol Natural products OC[C@@H](O)[C@H](O)CO UNXHWFMMPAWVPI-QWWZWVQMSA-N 0.000 abstract 1
- 206010014970 Ephelides Diseases 0.000 abstract 1
- 208000003351 Melanosis Diseases 0.000 abstract 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 abstract 1
- 150000003271 galactooligosaccharides Chemical class 0.000 abstract 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- 230000000968 intestinal effect Effects 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 229940093797 bioflavonoids Drugs 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000013402 health food Nutrition 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 241000186000 Bifidobacterium Species 0.000 description 2
- 241000186016 Bifidobacterium bifidum Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 208000015634 Rectal Neoplasms Diseases 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000001465 calcium Nutrition 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 2
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 206010038038 rectal cancer Diseases 0.000 description 2
- 201000001275 rectum cancer Diseases 0.000 description 2
- 239000003507 refrigerant Substances 0.000 description 2
- 238000001694 spray drying Methods 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- -1 tabletting Substances 0.000 description 2
- 208000006770 Ascorbic Acid Deficiency Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010047623 Vitamin C deficiency Diseases 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003167 anti-vitamin Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000020845 low-calorie diet Nutrition 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 230000001769 paralizing effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- SBNFWQZLDJGRLK-UHFFFAOYSA-N phenothrin Chemical compound CC1(C)C(C=C(C)C)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 SBNFWQZLDJGRLK-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 230000000291 postprandial effect Effects 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 208000010233 scurvy Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicinal Preparation (AREA)
Abstract
The invention provides chewable tablets containing acerola cherry powder and a preparation method of the chewable tablets. The chewable tablets are tabletting sweets made by using meso-erythritol, galactooligosaccharide, xylooligosaccharide, acerola cherry powder and kiwi fruit powder as main raw materials, have the functions of enhancing immunity, eliminating freckles, beautifying the features and delaying aging, and are convenient to take and worth of popularization and application.
Description
Technical field
The present invention relates to a kind of chewable tablet containing Malpighia glabra L. powder and preparation method thereof, belongs to field of health care food.
Background technology
Malpighia glabra L. be current plantation plant in Vitamin C content highest per 100 grams of fruits in Vc content reach 1800-4000 milligrams, it is 35 times of Fructus Citri Limoniae, 17 times of Fructus Fragariae Ananssae, also the Fructus psidii guajavae immaturus more high than being considered as vitamin C are high 11 times, it is genuine " king of natural complex C ", simultaneously also containing elements such as dimension A, dimension B1, dimension B2, ferrum, calcium, vitamin C is the important composition for maintaining human life integral, it anti-can catch a cold, anti- vitamin C deficiency, improve human body resistivity, have certain effect to beauty and cancer.Merely chemically composition aspect is not different the natural Vc of Malpighia glabra L. and synthesis Vc, is all L-AA, but in plant, the natural Vc and Vp (bioflavonoids) of Malpighia glabra L. are compound to be present.Bioflavonoids（Vp）Function be mainly reflected in the normal fragility of maintenance blood capillary and permeability.Vp can prevent Vc to be oxidized and destroyed, and help Vc to be more preferably absorbed by the body, and have the effect of potentiation to Vc, and bioflavonoids are referred to as the companion of Vc, not exist in synthesis Vc.Be prepared from using at present more advanced spray drying technology using Malpighia glabra L. powder, its original local flavor, vitamin composition are retained to greatest extent.
Unusual fruit powder is processed with the unusual fruit powder of high-quality as raw material using spray drying technology relatively advanced at present.The original flavor of kiwi fruit itself is maintained to greatest extent, containing multivitamin and fat, protein, aminoacid and calcium, phosphorus, ferrum, magnesium, pectin etc., wherein Vitamin C content is very high for kiwi fruit, 62 milligrams of vitamin C is contained per 100 grams of Fructus actinidiae chinensiss.
Oligomeric galactose is described as third generation functional factor, is one of internationally recognized prebioticses, and by U.S. FDA GRAS materials are confirmed as, by Japanese legislative orientation health food.Oligomeric galactose can be utilized by the selective zymolysis of bacillus bifiduss, and with probioticss such as the bacillus bifiduss in 40 times of incremental speed propagation human body intestinal canals, suppress the generation of harmful bacteria, regulating intestinal canal microecological balance, generation to be conducive to the health-care effect of host.Synthesis vitamin B group can be promoted, the absorption rate of protein is improved, promoted mineral absorption；Strengthen the colonization resistance and immunity of human body intestinal canal；Human body intestinal canal is promoted to wriggle.
Oligomeric xylose, also known as xylooligosaccharide, is the feature polymerization sugar being combined into β-Isosorbide-5-Nitrae glycosidic bond by 2-7 xylose molecule.There is unique advantage compared with the soybean oligo saccharide used by usual people, oligofructose, oligomeric isomaltose etc., it can selectively promote the proliferation activity of intestinal bifidobacteria.Its bifidobacterium factor functional is 10-20 times of other polymerization saccharides.Oligomeric xylose has and suppresses Oral Pathogens and diarrhoea, body can also be promoted to generate various nutrient substance, including vitamin B1, B2, B6, B12, nicotinic acid and Folic Acid the effects such as prevent constipation, the liver protecting function, reduce serum cholesterol, enhancing human body immunity power.
Food fibre powder, using imported raw material ----water soluble dietary fiber Fibersol-2, the product, with native starch as raw material, is a kind of current water soluble dietary fiber used as raw-food material unique in the world, and its fiber content is up to 85%-95%.The product has obtained U.S. FDA " popular safety and Health food（GRAS）" certification, and obtain Japanese " specific health food " certification.Dietary fiber belongs to low molecule water soluble dietary fiber, dietary fiber is referred to as " the 7th nutrient " by nutrition educational circles, the appropriate dietary fiber of supplement can effectively pre- preventing obesity, diabetes, coronary heart disease, rectal cancer, colon cancer etc., the moisture that dietary fiber passes through absorption stomach enteral, rapid expansion makes human body produce satiety, and reduce intestinal absorption saccharide, lipid material, lubrication intestinal, promotes defecation, suppresses fat.Dietary fiber can promote intestinal peristalsis promoting, soften stool, Constipation, colon cancer and rectal cancer；Cholesterol, the triglyceride in blood is reduced, beneficial to obesity control；Remove the skin problems such as vivotoxin, prevention mottle formation, comedo；Absorption of the saccharide in intestinal is reduced, post-prandial glycemia is reduced；Promote intestinal beneficial bacterium propagation, improve absorption of human body ability.
Erythritol heat is extremely low, is diabeticss and the preferable low-calorie diet of high blood glucose person.This product is achieved the low heat value of product from " 0 card " sugar alcohol --- erythritol, meets the demand of more consumer groups.Erythritol adopts fermentative Production, and closer to natural conversion and extraction, erythritol is the sweeting agent of natural zero-calorie, and impact of the erythritol to blood glucose is little, carbohydrate metabolism and change of blood sugar is not involved in, also with certain antioxidant activity.Erythritol is the hot highest of solution absorption, so its refrigerant sense is highest in sugar alcohol, after eating silk silk refrigerant sense is had.
The content of the invention
The present invention provides a kind of chewable tablet containing Malpighia glabra L. powder and preparation method thereof.This product is the oligomeric galactose with erythritol, oligomeric xylose, Malpighia glabra L. powder, pressed candy made by raw material is wanted based on unusual fruit powder, with enhancing immunity, spot-eliminating beauty treatment, the function of slow down aging.Simultaneously chewable tablet tablet surface area increase Jing after chewing, can promote nutritional labeling dissolving in vivo and absorption.Taking convenience, can swallow, chew to contain and suck or take after water-dispersible.Especially suitable old man, child, paralytic, swallow difficulty and gastrointestinal function difference patient.
The present invention provides a kind of chewable tablet containing Malpighia glabra L. powder, and the formula of chewable tablets is made up of the raw material of following percentage of weight parts：Erythritol 40-55 parts, unusual fruit powder 2-10 part, oligomeric galactose 5-15 parts, water soluble dietary fiber 15-35 parts, oligomeric xylose 1-6 parts, essence 0.1-1 parts, Malpighia glabra L. powder 5-12 parts, lubricant 0.5-1 parts.
The present invention provides a kind of chewable tablet containing Malpighia glabra L. powder, and the formula of chewable tablets is made up of the raw material of following percentage of weight parts：40 parts of erythritol, 10 parts of unusual fruit powder, 5 parts of oligomeric galactose, 35 parts of water soluble dietary fiber, oligomeric xylose 1,1 part of essence, 5 parts of Malpighia glabra L. powder, 1 part of lubricant.
A kind of chewable tablet containing Malpighia glabra L. powder that the present invention is provided, formula proportion weight portion is preferably：55 parts of erythritol, 2 parts of unusual fruit powder, 15 parts of oligomeric galactose, 15 parts of water soluble dietary fiber, 6 parts of oligomeric xylose, 0.1 part of essence, 12 parts of Malpighia glabra L. powder, 0.5 part of lubricant.
A kind of chewable tablet containing Malpighia glabra L. powder that the present invention is provided, formula proportion weight portion is preferably：46 parts of erythritol, 6 parts of unusual fruit powder, 10 parts of oligomeric galactose, 25 parts of water soluble dietary fiber, 3 parts of oligomeric xylose, 0.5 part of essence, 8.5 parts of Malpighia glabra L. powder, 0.8 part of lubricant.
A kind of chewable tablet containing Malpighia glabra L. powder that the present invention is provided, described essence is preferably Fructus Pruni pseudocerasi solid essence.
A kind of chewable tablet containing Malpighia glabra L. powder that the present invention is provided, described water soluble dietary fiber is preferably resistant dextrin.
A kind of chewable tablet containing Malpighia glabra L. powder that the present invention is provided, described lubricant is preferably magnesium stearate.
A kind of preparation method of chewable tablet containing Malpighia glabra L. powder that the present invention is provided is comprised the following steps：
（1）Crush, weigh：By other formula materials outside lubricant, sieve respectively, weigh respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained, granulation is dried, and granulate obtains dry particl；
（4）Tabletting：By step（3）Gained dry particl, adds formula ratio lubricant, mixing, tabletting.
A kind of preparation method containing Malpighia glabra L. powder chewable tablet that the present invention is provided is preferably：
（1）Crush, weigh：By other formula materials outside lubricant, 20-80 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 20-60 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 40-70 DEG C of drying, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, mixing 10-30 minutes in mixer are put, hybrid particles, tabletting are obtained, tablet format is 0.5-1g/ pieces.
A kind of preparation method containing Malpighia glabra L. powder chewable tablet that the present invention is provided is also preferably：
（1）Crush, weigh：By the erythritol outside lubricant, unusual fruit powder, oligomeric galactose, water soluble dietary fiber, oligomeric xylose, composition raw material, 60 mesh sieves are crossed respectively, Malpighia glabra L. powder is crossed 40 mesh, weighed respectively according to formula ratio, obtains weighing powder, standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 30 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 50 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, is put in mixer and is mixed 20 minutes, obtain hybrid particles, tabletting, piece weight-normality lattice are 0.7g/ pieces.
Specific embodiment
Embodiment 1
Formula：
Erythritol 46g, unusual fruit powder 6g, oligomeric galactose 10g, resistant dextrin 25g, oligomeric xylose 3g, cherry essence 0.5g, Malpighia glabra L. powder 8.5g, magnesium stearate 0.8g
Preparation method：
（1）Crush, weigh：By erythritol, unusual fruit powder, oligomeric galactose, resistant dextrin, oligomeric xylose, cherry essence formula material outside profit magnesium stearate, 60 mesh sieves are crossed respectively, Malpighia glabra L. powder is crossed 40 mesh, weighed respectively according to formula ratio, obtains weighing powder, standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 30 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 50 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 20 minutes, obtain hybrid particles, tabletting, piece weight-normality lattice are 0.7g/ pieces.
Embodiment 2
Formula：
Erythritol 40g, unusual fruit powder 10g, oligomeric galactose 5g, resistant dextrin 35g, oligomeric xylose 1g, cherry essence 1g, Malpighia glabra L. powder 5g, micropowder silica gel 1g
Preparation method：
（1）Crush, weigh：By other formula materials outside micropowder silica gel, 60 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 60 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 40 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The micropowder silica gel of formula ratio is added in gained dry particl, is put in mixer and is mixed 30 minutes, obtain hybrid particles, tabletting, tablet format is 0.5g/ pieces.
Embodiment 3
Formula：
Erythritol 55g, unusual fruit powder 2g, oligomeric galactose 15g, resistant dextrin 15g, oligomeric xylose 6g, milk flavour 0.1g, Malpighia glabra L. powder 12g, magnesium stearate 0.5g
Preparation method：
（1）Crush, weigh：By other formula materials outside magnesium stearate, 20 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 20 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 70 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 10 minutes, obtain hybrid particles, tabletting, tablet format is 1g/ pieces.
Embodiment 4
Formula：
Erythritol 42g, unusual fruit powder 8g, oligomeric galactose 8g, resistant dextrin 32g, oligomeric xylose 2g, cherry essence 0.8g, Malpighia glabra L. powder 11g, magnesium stearate 0.7g
Preparation method：
（1）Crush, weigh：By other formula materials outside magnesium stearate, 50 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 20 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 50 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 30 minutes, obtain hybrid particles, tabletting, piece weight-normality lattice are 0.8g/ pieces.
Embodiment 5
Formula：
Erythritol 50g, unusual fruit powder 3g, oligomeric galactose 8g, resistant dextrin 31g, oligomeric xylose 5g, cherry essence 0.2g, Malpighia glabra L. powder 6g, polyethylene glycol 6000 0.8g
Preparation method：
（1）Crush, weigh：By other formula materials outside polyethylene glycol 6000,70 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 60 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 70 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The polyethylene glycol 6000 of formula ratio is added in gained dry particl, is put in mixer and is mixed 10 minutes, obtain hybrid particles, tabletting, piece weight-normality lattice are 0.6g/ pieces.
Embodiment 6
Formula：
Erythritol 48g, unusual fruit powder 7g, oligomeric galactose 13g, resistant dextrin 30g, oligomeric xylose 5g, cherry essence 0.6g, Malpighia glabra L. powder 10g, magnesium stearate 0.9g
Preparation method：
（1）Crush, weigh：By other formula materials outside magnesium stearate, 50 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 40 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 60 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The magnesium stearate of formula ratio is added in gained dry particl, is put in mixer and is mixed 10 minutes, obtain hybrid particles, tabletting, piece weight-normality lattice are 0.9g/ pieces.
Test example：In order to identify the performance of chewable tablet, the evaluation group of 15 people is constituted by professional, with the hardness of chewable tablet, outward appearance, mouthfeel as index, the chewable tablet of above example is scored respectively, 10 points is full marks, illustrates the performance of chewable tablet preferably, and test concrete outcome is as follows：
From above result of the test, chewable tablet prepared by formula using embodiment 1-6 and preparation method thereof, the complete smooth, mouthfeel in surface is tasty and refreshing, fine and smooth, sweet and sour taste, free from extraneous odour, hardness is suitable, expert analysis mode illustrates the chewable tablet better performances prepared using present aspect method more than 8.5 points, is suitable for industrialized great production.
Claims (10)
1. a kind of chewable tablet containing Malpighia glabra L. powder, it is characterised in that the formula of chewable tablets is made up of the raw material of following percentage of weight parts：Erythritol 40-55 parts, unusual fruit powder 2-10 part, oligomeric galactose 5-15 parts, water soluble dietary fiber 15-35 parts, oligomeric xylose 1-6 parts, essence 0.1-1 parts, Malpighia glabra L. powder 5-12 parts, lubricant 0.5-1 parts.
2. chewable tablet according to claim 1, it is characterised in that the formula of chewable tablets is made up of the raw material of following percentage of weight parts：40 parts of erythritol, 10 parts of unusual fruit powder, 5 parts of oligomeric galactose, 35 parts of water soluble dietary fiber, 1 part of oligomeric xylose, 1 part of essence, 5 parts of Malpighia glabra L. powder, 1 part of lubricant.
3. chewable tablet according to claim 1, it is characterised in that the formula of chewable tablets is made up of the raw material of following percentage of weight parts：55 parts of erythritol, 2 parts of unusual fruit powder, 15 parts of oligomeric galactose, 15 parts of water soluble dietary fiber, 6 parts of oligomeric xylose, 0.1 part of essence, 12 parts of Malpighia glabra L. powder, 0.5 part of lubricant.
4. chewable tablet according to claim 1, it is characterised in that formula of chewable tablets is made up of the raw material of following percentage of weight parts：46 parts of erythritol, 6 parts of unusual fruit powder, 10 parts of oligomeric galactose, 25 parts of water soluble dietary fiber, 3 parts of oligomeric xylose, 0.5 part of essence, 8.5 parts of Malpighia glabra L. powder, 0.8 part of lubricant.
5. the chewable tablet according to any one of claim 1-4, it is characterised in that the essence is Fructus Pruni pseudocerasi solid essence.
6. the chewable tablet according to any one of claim 1-4, it is characterised in that the water soluble dietary fiber is resistant dextrin.
7. the chewable tablet according to any one of claim 1-4, it is characterised in that the lubricant is magnesium stearate.
8. according to any one of claim 1-4 chewable tablet preparation method, it is characterised in that comprise the following steps：
（1）Crush, weigh：By other formula materials outside lubricant, sieve respectively, weigh respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained, granulation is dried, and granulate obtains dry particl；
（4）Tabletting：By step（3）Gained dry particl, adds formula ratio lubricant, mixing, tabletting.
9. the preparation method of chewable tablet according to claim 8, it is characterised in that comprise the following steps：
（1）Crush, weigh：By other formula materials outside lubricant, 20-80 mesh sieves are crossed respectively, weighed respectively according to formula ratio, obtain weighing powder, it is standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 20-60 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 40-70 DEG C of drying, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, mixing 10-30 minutes in mixer are put, hybrid particles, tabletting are obtained, tablet format is 0.5-1g/ pieces.
10. the preparation method of chewable tablet according to claim 9, it is characterised in that comprise the following steps：
（1）Crush, weigh：By the erythritol outside lubricant, unusual fruit powder, oligomeric galactose, water soluble dietary fiber, oligomeric xylose, composition raw material, 60 mesh sieves are crossed respectively, Malpighia glabra L. powder is crossed 40 mesh, weighed respectively according to formula ratio, obtains weighing powder, standby；
（2）Mixing：By step（1）Gained weighs powder and is mixed, and in putting mixer, mixes 30 minutes, obtains total mixed powder；
（3）Granulation：By step（2）The total mixed powder of gained adopts wet granulation, crosses 16 mesh sieves, and 50 DEG C of dryings, granulate obtains dry particl, standby；
（4）Tabletting：In step（3）The lubricant of formula ratio is added in gained dry particl, is put in mixer and is mixed 20 minutes, obtain hybrid particles, tabletting, piece weight-normality lattice are 0.7g/ pieces.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510684507.8A CN106605904A (en) | 2015-10-22 | 2015-10-22 | Chewable tablets containing acerola cherry powder and preparation method of chewable tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510684507.8A CN106605904A (en) | 2015-10-22 | 2015-10-22 | Chewable tablets containing acerola cherry powder and preparation method of chewable tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106605904A true CN106605904A (en) | 2017-05-03 |
Family
ID=58611477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510684507.8A Pending CN106605904A (en) | 2015-10-22 | 2015-10-22 | Chewable tablets containing acerola cherry powder and preparation method of chewable tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106605904A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375467A (en) * | 2017-07-31 | 2017-11-24 | 湖州金诺康健康科技有限公司 | A kind of acerola concentrate VC polyphenol chewable tablets |
| CN109090249A (en) * | 2018-08-23 | 2018-12-28 | 李卫平 | A kind of goat milk piece and preparation method thereof assisting hair care |
| CN109418809A (en) * | 2017-08-26 | 2019-03-05 | 石家庄以岭药业股份有限公司 | A kind of prune chewable tablets and preparation method thereof |
| CN109567070A (en) * | 2018-12-12 | 2019-04-05 | 海南热带海洋学院 | A kind of acerola concentrate sea cucumber composite chewable tablet and preparation method thereof |
| CN109601809A (en) * | 2019-01-28 | 2019-04-12 | 江西美好时光生物科技有限公司 | A kind of resistance influenza, promotes solid beverage of immunity and preparation method thereof |
| CN111084355A (en) * | 2019-12-30 | 2020-05-01 | 东营广元生物科技股份有限公司 | Cranberry chewable tablet |
| CN111528387A (en) * | 2020-05-19 | 2020-08-14 | 天津尖峰弗兰德医药科技发展有限公司 | Plant-based composition for enhancing immunity and protecting respiratory system and preparation thereof |
| CN114097917A (en) * | 2021-10-15 | 2022-03-01 | 山东星光首创生物科技有限公司 | Tabletting candy for relaxing bowels and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011060585A1 (en) * | 2009-11-20 | 2011-05-26 | 天津天狮生物发展有限公司 | Chewable tablets including essences of five-colour fruits and vegetables and preparative methods thereof |
| CN103330208A (en) * | 2013-07-10 | 2013-10-02 | 山东禹城禹王生态食业有限公司 | Double-protein nutrient chewing tablet capable of raising spirit and preparation method thereof |
| CN103385471A (en) * | 2013-07-10 | 2013-11-13 | 山东禹城禹王生态食业有限公司 | Nutrition and healthcare double-protein chewing tablet and preparation method thereof |
-
2015
- 2015-10-22 CN CN201510684507.8A patent/CN106605904A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011060585A1 (en) * | 2009-11-20 | 2011-05-26 | 天津天狮生物发展有限公司 | Chewable tablets including essences of five-colour fruits and vegetables and preparative methods thereof |
| CN103330208A (en) * | 2013-07-10 | 2013-10-02 | 山东禹城禹王生态食业有限公司 | Double-protein nutrient chewing tablet capable of raising spirit and preparation method thereof |
| CN103385471A (en) * | 2013-07-10 | 2013-11-13 | 山东禹城禹王生态食业有限公司 | Nutrition and healthcare double-protein chewing tablet and preparation method thereof |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107375467A (en) * | 2017-07-31 | 2017-11-24 | 湖州金诺康健康科技有限公司 | A kind of acerola concentrate VC polyphenol chewable tablets |
| CN109418809A (en) * | 2017-08-26 | 2019-03-05 | 石家庄以岭药业股份有限公司 | A kind of prune chewable tablets and preparation method thereof |
| CN109090249A (en) * | 2018-08-23 | 2018-12-28 | 李卫平 | A kind of goat milk piece and preparation method thereof assisting hair care |
| CN109567070A (en) * | 2018-12-12 | 2019-04-05 | 海南热带海洋学院 | A kind of acerola concentrate sea cucumber composite chewable tablet and preparation method thereof |
| CN109601809A (en) * | 2019-01-28 | 2019-04-12 | 江西美好时光生物科技有限公司 | A kind of resistance influenza, promotes solid beverage of immunity and preparation method thereof |
| CN111084355A (en) * | 2019-12-30 | 2020-05-01 | 东营广元生物科技股份有限公司 | Cranberry chewable tablet |
| CN111528387A (en) * | 2020-05-19 | 2020-08-14 | 天津尖峰弗兰德医药科技发展有限公司 | Plant-based composition for enhancing immunity and protecting respiratory system and preparation thereof |
| CN114097917A (en) * | 2021-10-15 | 2022-03-01 | 山东星光首创生物科技有限公司 | Tabletting candy for relaxing bowels and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106605904A (en) | Chewable tablets containing acerola cherry powder and preparation method of chewable tablets | |
| CN107495355A (en) | A kind of fibrous type albumen meal replacement powder and preparation method thereof | |
| CN103053771B (en) | Nutritional and healthy fructose candy and preparation method thereof | |
| CN101828718B (en) | High-fiber fruit and vegetable nutrition package and preparation method thereof | |
| CN102224891B (en) | Sugar alcohol honey apple jam and preparation method thereof | |
| CN105360891A (en) | Flour having low glycemic index and making method thereof | |
| CN106509856A (en) | Chewing tablet containing collagen and preparation method thereof | |
| WO2018077276A1 (en) | Immunity-enhancing composition and preparation method therefor | |
| CN105379927A (en) | Low-calorie sugar-free hard candy containing meso-erythritol and preparation method thereof | |
| CN101496589A (en) | Dietary fiber chewing tablet | |
| CN101579126A (en) | Special meal nutritional food used for rehabilitation after partum and artificial abortion | |
| CN101683477A (en) | Composition for fat-reducing | |
| CN104664370A (en) | Chewable flax tablet | |
| CN107048164A (en) | A kind of low sugar rice cake | |
| CN107981291A (en) | A kind of jelly powder, jelly and preparation method thereof | |
| CN107094974A (en) | A kind of lycium ruthenicum health-care sweets and preparation method thereof | |
| CN101120713A (en) | Chewing tablets of soybean fruit milk and preparation method thereof | |
| CN103371318A (en) | Dietary nutrition replenishing food | |
| CN103766571A (en) | Stachyose-containing maca tablet candy and maca tablets | |
| KR20100064120A (en) | Constipation releaving health food composition containing aloe vera and aloe aborescens | |
| CN103005259A (en) | Xylitol puerarin chewable tablet and preparation technique thereof | |
| CN102475180A (en) | Low-calorie functionality leisure food rich in high fibre | |
| JPH0272843A (en) | Mineral supplement containing sugar alcohol | |
| CN105982034A (en) | Protein composite powder, meal replacement powder, and preparation method of same | |
| CN102429154B (en) | Prosomillet and sesame paste |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170503 |